ESR1 and breast cancer: The receiver operating characteristic (ROC) curve analysis of the microarray and quantitative real‐time polymerase chain reaction (qRT‐PCR) data suggests that LINC01116 can be a potential biomarker to distinguish ER+ from ER− breast cancer subtypes.